Literature DB >> 25008918

Differential responses of plasmacytoid dendritic cells to influenza virus and distinct viral pathogens.

Jaime M Thomas1, Zoltan Pos2, Jennifer Reinboth1, Richard Y Wang1, Ena Wang3, Gregory M Frank4, Paolo Lusso5, Giorgio Trinchieri6, Harvey J Alter1, Francesco M Marincola7, Emmanuel Thomas8.   

Abstract

UNLABELLED: Plasmacytoid dendritic cells (pDCs) are key components of the innate immune response that are capable of synthesizing and rapidly releasing vast amounts of type I interferons (IFNs), particularly IFN-α. Here we investigated whether pDCs, often regarded as a mere source of IFN, discriminate between various functionally discrete stimuli and to what extent this reflects differences in pDC responses other than IFN-α release. To examine the ability of pDCs to differentially respond to various doses of intact and infectious HIV, hepatitis C virus, and H1N1 influenza virus, whole-genome gene expression analysis, enzyme-linked immunosorbent assays, and flow cytometry were used to investigate pDC responses at the transcriptional, protein, and cellular levels. Our data demonstrate that pDCs respond differentially to various viral stimuli with significant changes in gene expression, including those involved in pDC activation, migration, viral endocytosis, survival, or apoptosis. In some cases, the expression of these genes was induced even at levels comparable to that of IFN-α. Interestingly, we also found that depending on the viral entity and the viral titer used for stimulation, induction of IFN-α gene expression and the actual release of IFN-α are not necessarily temporally coordinated. In addition, our data suggest that high-titer influenza A (H1N1) virus infection can stimulate rapid pDC apoptosis. IMPORTANCE: Plasmacytoid dendritic cells (pDCs) are key players in the viral immune response. With the host response to viral infection being dependent on specific virus characteristics, a thorough examination and comparison of pDC responses to various viruses at various titers is beneficial for the field of virology. Our study illustrates that pDC infection with influenza virus, HIV, or hepatitis C virus results in a unique and differential response to each virus. These results have implications for future virology research, vaccine development, and virology as a whole.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25008918      PMCID: PMC4178854          DOI: 10.1128/JVI.01501-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Viral evasion of the interferon system.

Authors:  Michael Gale; Ganes C Sen
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 2.  Redefining chronic viral infection.

Authors:  Herbert W Virgin; E John Wherry; Rafi Ahmed
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

Review 3.  HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking?

Authors:  Y J Rosenberg; A O Anderson; R Pabst
Journal:  Immunol Today       Date:  1998-01

4.  HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.

Authors:  Emmanuel Thomas; Veronica D Gonzalez; Qisheng Li; Ankit A Modi; Weiping Chen; Mazen Noureddin; Yaron Rotman; T Jake Liang
Journal:  Gastroenterology       Date:  2012-01-13       Impact factor: 22.682

Review 5.  Respiratory epithelial cells in innate immunity to influenza virus infection.

Authors:  Catherine J Sanders; Peter C Doherty; Paul G Thomas
Journal:  Cell Tissue Res       Date:  2010-09-17       Impact factor: 5.249

Review 6.  Plasmacytoid dendritic cells: recent progress and open questions.

Authors:  Boris Reizis; Anna Bunin; Hiyaa S Ghosh; Kanako L Lewis; Vanja Sisirak
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

Review 7.  Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

8.  Plasmacytoid dendritic cells are dispensable during primary influenza virus infection.

Authors:  Amaya I Wolf; Darya Buehler; Scott E Hensley; Lois L Cavanagh; E John Wherry; Philippe Kastner; Susan Chan; Wolfgang Weninger
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

Review 9.  Calling in the troops: regulation of inflammatory cell trafficking through innate cytokine/chemokine networks.

Authors:  Thais P Salazar-Mather; Kirsten L Hokeness
Journal:  Viral Immunol       Date:  2003       Impact factor: 2.257

10.  Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells.

Authors:  Gabrielle Lui; Olivier Manches; Juliette Angel; Jean-Paul Molens; Laurence Chaperot; Joël Plumas
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more
  16 in total

1.  Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.

Authors:  Zhenwu Luo; Lei Ma; Lumin Zhang; Lisa Martin; Zhuang Wan; Stephanie Warth; Andrew Kilby; Yong Gao; Pallavi Bhargava; Zhen Li; Hao Wu; Eric G Meissner; Zihai Li; J Michael Kilby; Guoyang Liao; Wei Jiang
Journal:  Vaccine       Date:  2015-12-22       Impact factor: 3.641

Review 2.  Interferons and viruses: an evolutionary arms race of molecular interactions.

Authors:  Hans-Heinrich Hoffmann; William M Schneider; Charles M Rice
Journal:  Trends Immunol       Date:  2015-02-20       Impact factor: 16.687

3.  Human pDCs preferentially sense enveloped hepatitis A virions.

Authors:  Zongdi Feng; You Li; Kevin L McKnight; Lucinda Hensley; Robert E Lanford; Christopher M Walker; Stanley M Lemon
Journal:  J Clin Invest       Date:  2014-11-21       Impact factor: 14.808

4.  Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells.

Authors:  Ping Ma; Zhenwu Luo; Jing Qian; Zhongfang Yan; Lumin Zhang; Lisa Martin; Ziyu Wang; Huan Xia; Fangfang Yu; Wei Jiang
Journal:  Vaccine       Date:  2020-01-14       Impact factor: 3.641

5.  Differential Inhibition of HIV Replication by the 12 Interferon Alpha Subtypes.

Authors:  Armando Espinosa Ortiz; Olivia Blake; Alexandra Tauzin; Calaiselvy Soundaramourty; Charles Joly-Beauparlant; Alexandre Nicolas; Arnaud Droit; Jacques Dutrieux; Jérôme Estaquier; Fabrizio Mammano
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

6.  HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.

Authors:  Héla Saïdi; Marlène Bras; Pauline Formaglio; Marie-Thérèse Melki; Bruno Charbit; Jean-Philippe Herbeuval; Marie-Lise Gougeon
Journal:  PLoS Pathog       Date:  2016-02-12       Impact factor: 6.823

7.  Downregulation of Interferon-β and Inhibition of TLR3 Expression are associated with Fatal Outcome of Severe Fever with Thrombocytopenia Syndrome.

Authors:  Peixin Song; Nan Zheng; Li Zhang; Yong Liu; Taoyu Chen; Changjun Bao; Zhifeng Li; Wei Yong; Yongyang Zhang; Chao Wu; Zhiwei Wu
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

Review 8.  Immune evasion of porcine enteric coronaviruses and viral modulation of antiviral innate signaling.

Authors:  Qingzhan Zhang; Dongwan Yoo
Journal:  Virus Res       Date:  2016-05-19       Impact factor: 3.303

Review 9.  Respiratory Mononuclear Phagocytes in Human Influenza A Virus Infection: Their Role in Immune Protection and As Targets of the Virus.

Authors:  Sindhu Vangeti; Meng Yu; Anna Smed-Sörensen
Journal:  Front Immunol       Date:  2018-07-03       Impact factor: 7.561

Review 10.  Die Another Way: Interplay between Influenza A Virus, Inflammation and Cell Death.

Authors:  Gabriel Laghlali; Kate E Lawlor; Michelle D Tate
Journal:  Viruses       Date:  2020-04-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.